GO
Gossamer Bio
GOSS·NASDAQSan Diego CAFounded 2015100 employees
Micro CapbiotechPublicPulmonologyImmunology
Platform: Seralutinib
Market Cap
$0.15B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (GOSS)
Loading GOSS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GOS-5370 | GOS-5370 | Phase 2/3 | 2 | TNFα | Parkinson'sPV | ||
| GOS-9676 | GOS-9676 | Phase 1/2 | 1 | PD-L1 | LGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)